Literature DB >> 2298609

Sequence analysis of HLA-DR4B1 subtypes: additional first domain variability is detected by oligonucleotide hybridization and nucleotide sequencing.

J S Lanchbury1, M A Hall, K I Welsh, G S Panayi.   

Abstract

The stimulating capacity of HLA-DR4 variants in mixed leukocyte culture correlates with variation in the polymorphic regions of the first domains of their DR beta 1 chains. Variability between amino acids 67 and 86 appears largely to determine HLA-DR4,Dw type. We have used a combination of a DR4B1-specific primer set in the polymerase chain reaction and specific oligonucleotide probes to examine DR4,Dw-associated nucleotide polymorphisms. Phenotype and gene frequencies are reported among 44 normal DR4 Caucasoids. Oligonucleotide probes were selected which enabled definition of Dw4-, w14-, w10-, w13-, and w15-associated sequences. Unexpectedly, several subjects were positive for Dw15 sequences which are usually characteristic of Oriental populations. Dw15 assignment was confirmed by nucleotide sequencing of DR4B1 polymerase chain reaction products. A pair of oligonucleotides informative for the glycine or valine dimorphism at position 86 was used to identify two novel DR4B1 alleles, designated 13.2 and 14.2. Nucleotide sequencing shows that these represent recombinants between third hypervariable regions associated with Dw13 and Dw14 and a codon for glycine at position 86 which is usually found associated with Dw4 and Dw15 sequences.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2298609     DOI: 10.1016/0198-8859(90)90110-b

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  20 in total

1.  Antigen-specific T cell recognition of affinity-purified and recombinant thyroid peroxidase in autoimmune thyroid disease.

Authors:  D L Ewins; P S Barnett; S Ratanachaiyavong; C Sharrock; J Lanchbury; A M McGregor; J P Banga
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-05-25       Impact factor: 16.971

3.  Nucleotide sequence of a novel HLA-DRB4B1 allele, DRB1*0409.

Authors:  J S Lanchbury; E E Jaeger; K I Welsh; G S Panayi
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

4.  Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain.

Authors:  E W Petersdorf; A G Smith; E M Mickelson; P J Martin; J A Hansen
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

5.  A novel HLA-DR4 haplotype generated by a rare recombinational event between DRB1 and DQA1 loci.

Authors:  C Carcassi; R Giorda; M Trucco; L Contu
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

6.  HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis.

Authors:  H Zetterquist; U Broomé; K Einarsson; O Olerup
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

7.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

8.  Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection.

Authors:  C Söderberg; S Larsson; S Bergstedt-Lindqvist; E Möller
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

9.  Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients.

Authors:  K A Boki; A A Drosos; A G Tzioufas; J S Lanchbury; G S Panayi; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

10.  An immunogenetic heterogeneity in multiple sclerosis.

Authors:  J Hillert; M Grönning; H Nyland; H Link; O Olerup
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.